Loading company…
Researchi Therapeutics develops liver disease treatments and liquid biopsy-based companion diagnostics.
Researchi Therapeutics, also known as Recerise, develops treatment strategies and diagnostic technology for liver disease. Its work includes liquid biopsy-based companion diagnostics informed by the liver’s roles in immunity and metabolism. Founded in 2000, the company is based in Seoul, South Korea, and raised KRW 7 billion in Series A funding in June 2022 from Timewise Investment, QUAD Ventures, Partners Investment, Creation Investment Advisory, and CKD Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in